🌟 Navigo Proteins GmbH at Halle Firmenlauf 2024! 🌟 We are super happy to have taken part at the Halle Firmenlauf 2024! It was a fantastic experience, filled with team spirit, energy, fun, and enthusiasm. A big thank you to everyone who made this event possible and to all the participants for making it such a memorable day. A special shoutout to our stellar team, 'Speedy Gonzales', for securing a spot in the Top 10! Congratulations to all! #Navigo #HalleFirmenlauf2024 #Top10 #TeamSpirit
Navigo Proteins GmbH
Biotechnologieforschung
Unique Affinity Solutions for Biopharmaceutical Manufacturing and Biotherapeutics
Info
Navigo Proteins GmbH is specialized in creating novel affinity ligands for PRECISION CAPTURING and PRECISION TARGETING. These proteins serve either as highly specific binders for affinity purification of complex biologics or as ligands in activ biotherapeutic or diagnostics molecules, respectively. Our unique protein engineering expertise is based on our proprietary Affilin® platform of different small and stable, yet highly engineerable scaffold proteins. We have built a robust, rapid and reliable high-throughput-based, robotics assisted protein engineering platform to design, produce, analyze and select suitable affinity ligand proteins, optimized for their tasks in industrial downstream processing or as biopharmaceutical drugs. Our PRECISION CAPTURING platform creates ligands which can bind literally any biologic and notably allow the downstream process to be Protein-A-like, with competitive binding capacities, caustic stabilities & usage-cycles, and flow rates. It is applicable for purifying any recombinant proteins, mAbs, viruses, VLP’s, cells, etc. Navigo works with renowned partners to convert its affinity ligands into ready-to-use, GMP-compliant affinity resins. Our PRECISION TARGETING platform creates ligands which bind any desired biologic in biopharmaceutical or in diagnostic use, e.g. radiopharmaceuticals, Affilin®-drug-conjugates, or theranostics, in which the same Affilin® binder is employed in diagnosis, treatment and treatment monitoring. The Navigo team is about 50 heads strong, steadily growing and the company was founded some 20 years ago as “Scil Proteins”. Navigo Proteins is based in Halle, S/W of Berlin, owned by UV-Cap and offers its expertise to interested pharma, biotech and life sciences companies. Managing Directors: Dr. Henning Afflerbach, Dr. Ulrich Haupts Imprint: see https://www.navigo-proteins.com/imprint
- Website
-
http://www.navigo-proteins.com
Externer Link zu Navigo Proteins GmbH
- Branche
- Biotechnologieforschung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Halle/Saale
- Art
- Privatunternehmen
- Gegründet
- 2017
- Spezialgebiete
- Protein Engineering, Affinity Chromatography, Downstream Processing, Protein-Drug-Conjugates, target specific delivery und Radiopharmaceuticals
Orte
-
Primär
Wegbeschreibung
Heinrich-Damerow-Str. 1
Halle/Saale, 06120, DE
Beschäftigte von Navigo Proteins GmbH
-
Andreas Richter
Chief Financial Officer at Navigo Proteins GmbH
-
Clemens Moritz
Senior Manager Controlling & Accounting
-
Ulrich Haupts
Chief Scientific Officer & Managing Director bei Navigo Proteins GmbH
-
Michael N.
Teamleiter bei Navigo Proteins GmbH | Proteinanalytik & Downstreamentwicklung, Dr. in Biochemie
Updates
-
We are excited to join the SNMMI in Toronto from June 8 to 11! Targeted radiotheranostics are taking center stage, and we are proud to be part of the community pushing the boundaries for the benefit of patients. You can meet Chris-Carol Bremer (CDO) and Ulrich Haupts (CSO) from Navigo Proteins GmbH to learn how our proprietary Affilin® target-binding proteins can help you to advance your developments even faster. #navigoproteins #precisiontargeting #precisionmedicine #oncology #innovation #nextgenerationconjugates #radiotheranostics #radiopharmaceuticals #biotech
-
-
It was a pleasure to discuss business opportunities in South Korea. Thank you, KOTRA and a special thanks to Technologiepark Weinberg Campus and Life Science Sachsen-Anhalt e.V. for the organization.
𝗦𝗼𝘂𝘁𝗵 𝗞𝗼𝗿𝗲𝗮 𝗺𝗲𝗲𝘁𝘀 𝗪𝗲𝗶𝗻𝗯𝗲𝗿𝗴 𝗖𝗮𝗺𝗽𝘂𝘀 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗣𝗮𝗿𝗸 Wie können sich Biotech-Unternehmen und Startups aus Südkorea und Deutschland austauschen, kooperieren und voneinander profitieren? Das sind Themen des Besuches einer Delegation des koreanischen Bio-Clusters „Hong-Neung Innopolis“ in Verbindung mit der KOTRA, einer südkoreanischen Trade-Investment Promotion Agentur, welche die Handels- und Investitionskooperationen zwischen den beiden Ländern fördert. Heute starteten die Gespräche im Weinberg Campus Innovation Hub, an denen unter anderem die Navigo Proteins GmbH, die Icon Genetics GmbH und die Heppe Medical Chitosan GmbH teilnahmen. Mit Life Science Sachsen-Anhalt e.V. und Kompetenzzentrum Wasserwirtschaft
-
-
We are happy to announce that Navigo Proteins GmbH will be attending the Bio International Convention in San Diego! Navigo Proteins is a fast-growing German biopharmaceutical company at a near-clinical stage, focused on developing next-generation targeted therapies for Precision Medicine. Our proprietary platform, protected by strong IP, features therapeutic proteins known as Affilins®. Affilins® are innovative target-binding therapeutic proteins that combine the benefits of antibodies and peptides. They offer several advantages, including smaller size, improved tumor penetration, excellent stability, and a straightforward, scalable production process. Meet Chris-Carol Bremer (CDO) and Michael Hamm (Head of BD) to discover how our Affilin® ligands can accelerate the development of targeted therapeutics into clinical stages! #navigoproteins #BIOconvention #precisiontargeting #precisionmedicine #oncology #innovation #nextgenerationconjugates #theranostics #radiopharmaceuticals #biotech
-
-
Navigo Proteins GmbH is delighted to attend the 5th SLAS Europe 2024 Conference in Barcelona next week! We are excited to gain valuable insights to further enhance our technologies and drive innovations in life sciences. Stay tuned for exciting updates! 🚀 #navigoproteins #SLASEurope2024 #proteinengineering #affinitychromatography #purifucation #precisionmedicine #precisiontargeting #oncology #radiopharmaceuticals #innovation #lifescience
-
-
🚀 Exciting News! 🚀 We are delighted to share that Navigo Proteins GmbH will be attending the PEGS Boston 2024! Both of our business units will be represented at the event. As pioneers in the field of protein purification, we are eager to showcase our cutting-edge Next-Gen Affinity Chromatography technology. Additionally, we'll spotlight our other business unit's innovative solutions of advancing Affilin®-based therapeutics in biotechnology. Join us at PEGS Boston 2024 to explore how our expertise and diverse capabilities can accelerate your research and development efforts. Let's connect, collaborate, and shape the future of biotechnology together! #NavigoProteins #PEGSBoston #protein #innovation #NextGen #biotech
-
-
Join us at BioProcess International Europe in Vienna to discover how Navigo Proteins GmbH is shaping the future with next-gen Affinity Chromatography solutions. We look forward to meeting you and discussing how we can collaborate to drive innovation and efficiency in the biopharmaceutical industry. See you in Vienna! #downstream #biotech #pharma #affinitychromatography #purification
-
-
Wir freuen uns, in diesem Jahr die "Jugend forscht"-Initiative in Sachsen-Anhalt unterstützen zu können. Für die kommende Woche wünschen wir dem MINT-Nachwuchs eine erfolgreiche Präsentation ihrer Projekte und allen Teilnehmenden eine inspirierende Veranstaltung. #jugendforscht #wissenschaft #mint
𝗘𝗜𝗡𝗙𝗔𝗖𝗛 𝗗𝗔𝗡𝗞𝗘! ❤️ Jugend forscht und Schüler experimentieren steht in diesem Jahr unter dem Motto "Mach dir einen Kopf". 🧠 Scheinbar ein Aufruf, auf den die Jungforschenden gewartet haben, denn in diesem Jahr gibt es mehr Anmeldungen und wieder einmal beeindruckende Projekte. Die besten Arbeiten aus #SachsenAnhalt werden am 🔜 4. und 5. April beim Landeswettbewerb präsentiert. Damit dieser erneut am Technologiepark Weinberg Campus in hoher Qualität stattfinden kann, haben sich ebenfalls viele Menschen einen Kopf gemacht. Grund genug, allen Partnerinnen und Partnern schon vorab unseren herzlichsten Dank für die großartige Unterstützung auszusprechen! 🙏 𝗣𝗿𝗲𝗺𝗶𝘂𝗺𝗽𝗮𝗿𝘁𝗻𝗲𝗿 ▪ IHK Halle-Dessau ▪ GISA GmbH 𝗕𝗲𝘀𝗼𝗻𝗱𝗲𝗿𝗲 𝗨𝗻𝘁𝗲𝗿𝘀𝘁ü𝘁𝘇𝗲𝗿 ▪ Stadtwerke Halle GmbH ▪ Weinberg Campus e.V. ▪ Saalesparkasse ▪ Universitätsmedizin Halle ▪ SONOTEC GmbH ▪ Navigo Proteins GmbH ▪ Investitions- und Marketinggesellschaft Sachsen-Anhalt mbH ▪ Ministerium für Bildung des Landes Sachsen-Anhalt ▪ Stadt Halle (Saale) ▪ Fraunhofer Institute for Microstructure of Materials and Systems IMWS ▪ Roy Coffee Hub #jugendforscht #wissenschaft #nachwuchs Stiftung Jugend forscht e. V.
-
Meet us at the 7th Theranostics World Congress in Santiago de Chile on March 22-24! At Navigo, we apply our expertise in Precision Medicine to custom-design unique, targeted radiotheranostics based on proprietary target binding proteins called Affilins® for the benefits of patients. We are proud to sponsor the 7th Theranostics World Congress and are looking forward to connect to the scientific community hearing about the latest exciting advances in the field. Meet Chris-Carol Bremer (CDO) and Michael Hamm (Head of BD), if you want to collaborate for new projects to help patients in need. #theranostics #imaging #radiopharmaceuticals #TWC2024 #radiomolecular #precisionmedicine #precisiontargeting #oncology #innovation
-
-
Join us in Barcelona at BIO-EUROPE Spring 2024 to see the progress of Navigo Proteins next-generation targeting based on our unique, proprietary Affilin® platform! With a primary focus in Oncology, Affilins® are being developed as radio-conjugates for imaging and therapy (#rlt), protein-drug conjugates (#adc), Affilin®-CARs (#celltherapy) and multi-specifics through our in-house initiatives and partnered programs. Reach out to Chris-Carol Bremer (CDO) and Michael Hamm (Head of BD) to explore how our readily accessible Affilin® ligands can drive targeted therapeutics into clinical development! #bioeuropespring #precisiontargeting for #precisionmedicine #oncology #innovation #nextgenerationconjugates
-